Press Releases

03/11/15 7:01 am EDT
Tenax Therapeutics to Provide Corporate Update and Discuss Third Quarter Fiscal Year 2015 Financial Results on March 18, 2015
03/05/15 7:45 am EST
Tenax Therapeutics Highlights Recent Scientific Publications on Levosimendan
02/26/15 9:20 am EST
How It All Plays Out: Latest Research on PAREXEL, Senomyx, Sorrento Therapeutics, Tenax Therapeutics, and Charles River
02/23/15 4:30 pm EST
Tenax Therapeutics to Present at Cowen & Company 35th Annual Health Care Conference
02/20/15 4:30 pm EST
Tenax Therapeutics Issues Employment Inducement Award With Appointment of Paula Bokesch, M.D., as Chief Medical Officer
02/03/15 7:45 am EST
Tenax Therapeutics Announces Appointment of Paula Bokesch, M.D., as Chief Medical Officer
12/17/14 6:00 am EST
Tenax Therapeutics Announces Second Quarter Fiscal Year 2015 Financial Results
12/10/14 4:45 pm EST
Tenax Therapeutics to Provide Corporate Update and Discuss Second Quarter Fiscal Year 2015 Financial Results on December 17, 2014
11/25/14 7:00 am EST
Small Cap IR Issues Tenax Therapeutics Analyst Report: Large Validated Market Opportunity Inspires $12 Price Target
10/31/14 7:00 am EDT
Tenax Therapeutics Analyst Brief: Emerging Biopharmaceutical Player Back In the Clinical Trial Business -- Technical Exhaustion Setup Playing Out by Small Cap Traders
09/24/14 8:00 am EDT
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
09/22/14 8:30 am EDT
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS Clinical Trial of Levosimendan
09/19/14 8:30 am EDT
Tenax Therapeutics to Provide Corporate Update and Discuss First Quarter Fiscal Year 2015 Financial Results on September 24, 2014